Greenstreet Yvonne bought ALNY
November 13, 2025 · Form 4 insider transaction
Greenstreet Yvonne bought 10,000 shares of Alnylam Pharmaceuticals, Inc. at $119.13 per share, a transaction worth $1.19M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$119.13
Total value
$1.19M
InsiderGreenstreet Yvonne
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 13, 2025
Filing dateNovember 14, 2025
Shares owned after75,409
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 13, 2025.